This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Tenaris (TS) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Tenaris (TS) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's What Key Metrics Tell Us About Tenaris S.A. (TS) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Tenaris S.A. (TS) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Should You Buy Tenaris (TS) Ahead of Earnings?
by Zacks Equity Research
Tenaris (TS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Offing for Ingersoll Rand (IR) in Q3 Earnings?
by Zacks Equity Research
Ingersoll Rand's (IR) Q3 results are likely to benefit from solid demand, pricing actions and contributions from acquisitions.
Will Cost Headwinds Mar Parker-Hannifin's (PH) Q1 Earnings?
by Zacks Equity Research
While steady demand across end markets is expected to aid Parker-Hannifin's (PH) Q1 results, the escalating cost of sales may affect earnings.
Can Xylem (XYL) Retain Beat Streak This Earnings Season?
by Zacks Equity Research
Xylem's (XYL) Q3 results are likely to reflect benefits from the Evoqua acquisition. However, cost inflation and weakness in the residential end market may hurt results.
What's in Store for Zebra Technologies (ZBRA) in Q3 Earnings?
by Zacks Equity Research
Zebra Technologies' (ZBRA) Q3 results are likely to benefit from cost-control measures and improving supply chains, partly offset by weakness in the mobile computing market.
What's in the Offing for Stanley Black (SWK) in Q3 Earnings?
by Zacks Equity Research
Stanley Black's (SWK) Q3 results are likely to be hurt by lower volumes. However, cost-control measures are expected to drive earnings.
Will Honeywell (HON) Beat on Q3 Earnings on Aerospace Strength?
by Zacks Equity Research
Honeywell's (HON) Q3 results are likely to benefit from strength in commercial aerospace, process solutions and UOP operations.
Can Application Software Strength Lift Roper (ROP) Q3 Earnings?
by Zacks Equity Research
Roper's (ROP) Q3 earnings results are expected to reflect solid performance of the Application Software unit due to growth in the Deltek, Vertafore and Aderant businesses.
Will Diagnostic Unit Weakness Mar Danaher's (DHR) Q3 Earnings?
by Zacks Equity Research
Danaher's (DHR) Q3 results are likely to be hurt by weakness in the Biotechnology and Diagnostics segments due to a decrease in the sale of COVID-related products.
Will Low Demand Environment Dent 3M's (MMM) Q3 Earnings?
by Zacks Equity Research
3M's (MMM) Q3 results are expected to be hurt by lower disposable respirator demand, reduced consumer electronics demand and cost inflation.
What's in the Offing for Alcoa (AA) This Earnings Season?
by Zacks Equity Research
Alcoa's (AA) Q3 performance is expected to bear the brunt of lower alumina production and softer billet demand.
Tenaris (TS) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Tenaris' (TS) Q2 performance is likely to have been hurt by lower prices and a reduction in U.S. drilling activity. A decline in raw material and energy costs is expected to have driven earnings.
Can Roper (ROP) Retain Beat Streak This Earnings Season?
by Zacks Equity Research
Roper's (ROP) Q2 earnings are expected to have benefited from robust customer demand and a strong pipeline of orders. However, supply chain issues and cost inflation might have weighed on performance.
Alcoa (AA) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Alcoa's (AA) Q2 performance is likely to have been hurt by lower shipments of alumina and aluminum, partly offset by higher prices.
Tenaris S.A. (TS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Tenaris S.A. (TS) closed at $29.71, marking a -0.54% move from the previous day.
Is Trending Stock Tenaris S.A. (TS) a Buy Now?
by Zacks Equity Research
Tenaris S.A. (TS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Tenaris S.A. (TS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Tenaris S.A. (TS) closed at $28.39, marking a +1.21% move from the previous day.
Tenaris S.A. (TS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Tenaris S.A. (TS) closed the most recent trading day at $27.70, moving -1.95% from the previous trading session.
Tenaris S.A. (TS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Tenaris S.A. (TS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenaris S.A. (TS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Tenaris S.A. (TS) closed at $27.89, marking a -0.71% move from the previous day.
Tenaris S.A. (TS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Tenaris S.A. (TS) closed the most recent trading day at $27.78, moving +0.18% from the previous trading session.
Tenaris S.A. (TS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Tenaris S.A. (TS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is It Worth Investing in Tenaris S.A. (TS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tenaris S.A. (TS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?